×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Institute of Chi... [1]
Faculty of Healt... [1]
Authors
Lu Ruyuan2 [1]
ZHONG ZHANGFENG [1]
Document Type
Journal article [2]
Date Issued
2024 [1]
2023 [1]
Language
英語English [2]
Source Publication
Human Genomics [1]
Journal of Men''... [1]
Indexed By
SCIE [2]
SSCI [1]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-2 of 2
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Pan-cancer analysis of CDKN2A alterations identifies a subset of gastric cancer with a cold tumor immune microenvironment
Journal article
Deng, Chao, Li, Zi Xi, Xie, Chen Jun, Zhang, Qing Lin, Hu, Ben Shun, Wang, Mei Dan, Mei, Jie, Yang, Chen, Zhong, Zhangfeng, Wang, Ke Wei. Pan-cancer analysis of CDKN2A alterations identifies a subset of gastric cancer with a cold tumor immune microenvironment[J]. Human Genomics, 2024, 18(1), 55.
Authors:
Deng, Chao
;
Li, Zi Xi
;
Xie, Chen Jun
;
Zhang, Qing Lin
;
Hu, Ben Shun
; et al.
Favorite
|
TC[WOS]:
2
TC[Scopus]:
2
IF:
3.8
/
4.0
|
Submit date:2024/07/04
Cdkn2a
Immune Checkpoint Inhibitor
Immunotherapy
Pan-cancer
Stratification of risk based on immune signatures and prediction of the efficacy of immune checkpoint inhibitors in prostate cancer
Journal article
Sun, Yidan, Yang, Xinyu, Ren, Shiqi, Lu, Zhichao, Liu, Zongheng, Kong, Fanming, Wang, Ziheng, Yang, Yang. Stratification of risk based on immune signatures and prediction of the efficacy of immune checkpoint inhibitors in prostate cancer[J]. Journal of Men's Health, 2023, 19(11), 16-33.
Authors:
Sun, Yidan
;
Yang, Xinyu
;
Ren, Shiqi
;
Lu, Zhichao
;
Liu, Zongheng
; et al.
Favorite
|
TC[WOS]:
4
TC[Scopus]:
4
IF:
0.6
/
0.6
|
Submit date:2024/01/10
Immune Checkpoint Inhibitor
Immunotherapy
Prognostic Model
Prostate Cancer
Tumor Immune Microenvironment